Research digest
Ipamorelin is the peptide they tested to wake the gut back up.
A fast, plain-English read on the ghrelin-receptor science — the appetite signal, the gut-motility studies, the one human trial — with every quantitative claim cited.

The gist
Here's Ipamorelin in one line: a tiny five-piece peptide (a short chain of amino-acid building blocks) that flips the same switch your hunger hormone flips. That switch is the ghrelin receptor — labs call it GHS-R1a — and ghrelin is the hormone your stomach releases when it wants food and wants the gut moving [1].
Because of that, the most-tested idea for ipamorelin wasn't muscle or anti-aging. It was the gut: researchers gave it to animals (and once to people) to see if it could restart bowel movement that stalls after surgery [3][9][10]. When the ghrelin switch flips, the pituitary gland in the brain also fires off a short burst of growth hormone [1][2].
What's the catch? The one human trial of ipamorelin didn't hit its goal [3], it has never been an approved medicine, and the popular benefits are mostly stories, not proof. The honest version — including the downsides people report — is on the effects page.
What the Ipamorelin research actually measured
Ipamorelin is a synthetic pentapeptide (a chain of five amino acids: Aib-His-D-2-Nal-D-Phe-Lys-NH2). Its whole reason for existing is a single trick: in its founding study it released growth hormone as strongly as the older peptide GHRP-6 — but, unlike the older ones, it barely touched cortisol (the stress hormone) or prolactin, even at doses more than 200 times higher than the dose needed for GH [1]. That clean, one-job profile is its signature. Scientists call it the first highly GH-selective growth hormone secretagogue [1].
The gut angle comes from the receptor. The ghrelin receptor sits not only on the pituitary but on the nerves that drive gastric motility — the muscular squeezing that moves food along. Activate it, and in animals the stomach empties faster and the bowel wakes up [9][10][11]. That is the research thread this site leads with.
What about people? The human file is small and mostly disappointing. One pharmacology study mapped its kinetics, finding a terminal half-life of about two hours after an IV dose [2]. One mid-stage trial put it to the test in patients recovering from bowel surgery — and it missed its goal [3].
Why "telehealth" is in the name but not in the building
Quick, important note: this domain has "telehealth" in it, but this is an independent reading list, not a clinic. We don't prescribe, consult, sell, or ship anything. There is no doctor behind the name and no checkout button anywhere on the site. What you'll find is a plain-English digest of the published Ipamorelin research — the studies, the doses used in those studies (in animals or trials, never as advice for you), and an honest accounting of what's proven versus what's just popular online.
If you came looking to buy something or get a protocol, this isn't that. If you came to actually understand what the research found and what people report, you're in the right spot — start with Ipamorelin effects for the human-interest side, or dig into the studies on Ipamorelin research.
Where to go next
- Curious whether it spikes appetite? That question gets its own deep dive: does ipamorelin make you hungry.
- Want the mechanism in plain words? Start with what does ipamorelin peptide do.
- Want the studies and the numbers? The Ipamorelin research page lays out the mechanism, the gut-motility data, and the failed human trial.
- Want the honest upside-and-downside list? Ipamorelin effects covers what people report (clearly labeled anecdotal) plus the cited safety cautions.
- Want every source? They're all on Ipamorelin references, with PubMed links and DOIs.